<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">epidemiology</journal-id><journal-title-group><journal-title xml:lang="ru">Эпидемиология и Вакцинопрофилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Epidemiology and Vaccinal Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2073-3046</issn><issn pub-type="epub">2619-0494</issn><publisher><publisher-name>«Numicom» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31631/2073-3046-2022-21-1-56-60</article-id><article-id custom-type="elpub" pub-id-type="custom">epidemiology-1459</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Термины и определения. Всегда ли трудности перевода?</article-title><trans-title-group xml:lang="en"><trans-title>Terms and Definitions. Is it Always Difficult to Translate?</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3810-4804</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Цвиркун</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Tsvirkun</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ольга Валентиновна Цвиркун – д. м. н., руководитель эпидемиологического отдела; доцент кафедры инфекционных болезней с курсами эпидемиологии и фтизиатрии</p><p>Москва</p><p>+7 (495) 452-18-09</p></bio><bio xml:lang="en"><p>Olga V. Tsvirkun – Dr. Sci. (Med.), head of the epidemiological department; associate Professor of the Department of Infectious Diseases with courses of Epidemiology and Phthisiology</p><p>Moscow</p><p>+7 (495) 452-18-09</p></bio><email xlink:type="simple">o.tsvirkun@gabrich.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФБУН «Московский НИИ эпидемиологии и микробиологии им. Г. Н. Габричевского» Роспотребнадзора; ФГАОУ ВО «Российский университет дружбы народов»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>G. N. Gabrichevsky Research Institute for Epidemiology and Microbiology of Rospotrebnadzor; "Peoples' Friendship University of Russia" (RUDN)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>15</day><month>03</month><year>2022</year></pub-date><volume>21</volume><issue>1</issue><fpage>56</fpage><lpage>60</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Цвиркун О.В., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Цвиркун О.В.</copyright-holder><copyright-holder xml:lang="en">Tsvirkun O.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.epidemvac.ru/jour/article/view/1459">https://www.epidemvac.ru/jour/article/view/1459</self-uri><abstract><sec><title>Актуальность</title><p>Актуальность. Английский язык принят в мировом медицинском сообществе языком общения. Научные публикации сконцентрированы в англоязычных информационных базах и электронных библиотеках, крупные международные научные конференции проводятся на английском языке. </p></sec><sec><title>Цель</title><p>Цель. Сопоставить смысловое наполнение в эпидемиологии понятий «мониторинг» и «скрининг» в английской и русскоязычной медицинской литературе.</p></sec><sec><title>Заключение</title><p>Заключение. Проведенный анализ показал, что понятие «мониторинг» совпадает по смыслу в обоих языках. В то же время имеются существенные расхождения в определениях понятия «скрининг» в эпидемиологическом и серологическом надзоре. Хотелось бы сформулировать это понятие так, чтобы оно было понятно специалистам разных медицинских специальностей, что существенно упростит не только преподавание иностранным студентам медицинских вузов основных определений в разделе «эпидемиология», но и будет способствовать взаимопониманию медицинских работников одной специальности в разных странах.</p></sec></abstract><trans-abstract xml:lang="en"><p>Conclusion. The analysis showed that the concept of «monitoring» in epidemiology coincides in both languages. At the same time, there are significant differences in the definitions of the term «screening» in epidemiological and serological surveillance. For instance: methods of serological studies of the state of collective immunity of the organization of the survey differ in such parameters as orientation (cross-sectional, longitudinal), as regularity (annually, irregularly), according to the principles of stratification (by territorial, by age group, professional, vaccination history, financing). The analysis showed that the concept of «monitoring» in epidemiology coincides in both languages. At the same time, there are significant differences in the definitions of the term «screening» in epidemiological and serological surveillance. I would like to harmonize this term among different medical specialists, which will significantly simplify not only teaching foreign students of medical universities the basic definitions in the epidemiology section but will also contribute to a mutual understanding of medical workers of the same specialty in different countries when meeting with certain terms in medical publications and communication. We would like to harmonize this term among different medical specialists, which will greatly simplify not only the teaching of basic concepts in the section «epidemiology» to foreign medical students but will also facilitate mutual understanding among physicians of the same specialty in different countries, when encountering these or those terms in medical publications and for communication.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>эпидемиологический надзор</kwd><kwd>мониторинг</kwd><kwd>скрининг</kwd><kwd>популяционный иммунитет</kwd></kwd-group><kwd-group xml:lang="en"><kwd>epidemiological surveillance</kwd><kwd>monitoring</kwd><kwd>screening</kwd><kwd>population immunity</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Эпидемиологический словарь. Четвертое издание. Под редакцией Джона М. Ласта для Международной эпидемиологической ассоциации. Москва, 2009 – 316 с.</mixed-citation><mixed-citation xml:lang="en">Epidemiological dictionary. Fourth edition. Ed.: John M. Last for the International Epidemiological Association. Moscow. 2009:316.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Симонова Е. Г. Современный этап развития эпидемиологического надзора и перспективы его совершенствования. Эпидемиология и Вакцинопрофилактика 2016;4(95):4–7. https://doi.org/10.31631/2073-3046-2017-16-4-4-7</mixed-citation><mixed-citation xml:lang="en">Simonova E.G. Modern Stage of Development of the Epidemiological Surveillance and Prospects of its Improvement. Epidemiology and Vaccinal Prevention. 2017;16(4):4–7 (In Russ.). https://doi.org/10.31631/2073-3046-2017-16-4-4-7</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Центр по контролю и профилактике заболеваний (CDC). www.cdc.gov</mixed-citation><mixed-citation xml:lang="en">Center for Disease Control and Prevention (CDC). www.cdc.gov</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">World Health Organization. Guidance on conducting serosurveys in support of measles and rubella elimination in the WHO European Region. Copenhagen. 2013;19. Доступно на: https://www.euro.who.int/en/health-topics</mixed-citation><mixed-citation xml:lang="en">World Health Organization. Guidance on conducting serosurveys in support of measles and rubella elimination in the WHO European Region. Copenhagen. 2013:19. Avail- able аt: https://www.euro.who.int/en/health-topics</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Pei L, YangYu, Zhao X, Zhang S, Yuan L, LiuY, et al. Identify the susceptibility profile to measles in the general population: Serological survey of measles antibodies in Shaanxi province, China, in 2016. Vaccine. 2017 Dec 19;35(52):7250–7255. doi: 10.1016/j.vaccine.2017.11.012</mixed-citation><mixed-citation xml:lang="en">Pei L, YangYu, Zhao X, Zhang S, Yuan L, Liu Y, et al. Identify the susceptibility profile to measles in the general population: Serological survey of measles antibodies in Shaanxi province, China, in 2016. Vaccine. 2017 Dec 19;35(52):7250–7255. doi: 10.1016/j.vaccine.2017.11.012</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Izadi, S., Zahraei, S. M. &amp; Mokhtari-Azad, T. Seroprevalence of antibodies to measles and rubella eight months after a vaccination campaign in the southeast of Iran. Hum Vaccin Immunother. 2018:1412–1416.</mixed-citation><mixed-citation xml:lang="en">Izadi, S., Zahraei, S. M. &amp; Mokhtari-Azad, T. Seroprevalence of antibodies to measles and rubella eight months after a vaccination campaign in the southeast of Iran. Hum Vaccin Immunother. 2018:1412–1416.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Xiong, Y., WangD., Lin W., TangH., Chen S., Ni J. Age-related changes in serological susceptibility patterns to measles: results from a seroepidemiological study in Dongguan, China. Hum Vaccin Immunother. 2014:1097–1103.</mixed-citation><mixed-citation xml:lang="en">Xiong, Y., Wang D., Lin W., Tang H., Chen S., Ni J. Age-related changes in serological susceptibility patterns to measles: results from a seroepidemiological study in Dongguan, China. Hum Vaccin Immunother. 2014:1097–1103.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Coppeta, L., D’Alessandro, I., Pietroiusti, A., et al. Seroprevalence for vaccine-preventable diseases among Italian healthcare workers. Human Vaccines and Immunotherapeu- tics 2021;17(5):1342–1346. https://doi.org/10.1080/21645515.2020.1818523</mixed-citation><mixed-citation xml:lang="en">Coppeta, L., D’Alessandro, I., Pietroiusti, A., et al. Seroprevalence for vaccine-preventable diseases among Italian healthcare workers. Human Vaccines and Immunotherapeu- tics 2021;17(5):1342–1346. https://doi.org/10.1080/21645515.2020.1818523</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Lebo E. J. , Kruszon-Moran D. M., Marin M, Bellini W. J., Schmid S., Bialek S. R., et al. Seroprevalence of measles, mumps, rubella and varicella antibodies in the United States population, 2009–2010. Open Forum Infect Dis. 2015 Feb 20;2(1):ofv006. doi: 10.1093/ofid/ofv006</mixed-citation><mixed-citation xml:lang="en">Lebo E. J. , Kruszon-Moran D. M., Marin M, Bellini W. J., Schmid S., Bialek S. R., et al. Seroprevalence of measles, mumps, rubella and varicella antibodies in the United States population, 2009–2010. Open Forum Infect Dis. 2015 Feb 20;2(1):ofv006. doi: 10.1093/ofid/ofv006</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Bassal R., V. Indenbaum, R. Pando, T. Levin, et al. Seropositivity of measles antibodies in the Israeli population prior to the nationwide 2018 - 2019 outbreak. Hum Vaccin Im- munother, 2021 May 4;17(5):1353–1357. doi: 10.1080/21645515.2020.1824968</mixed-citation><mixed-citation xml:lang="en">Bassal R, Indenbaum V, Pando R, Levin T, et al. Seropositivity of measles antibodies in the Israeli population prior to the nationwide 2018–2019 outbreak. Hum Vaccin Im- munother, 2021 May 4;17(5):1353–1357. doi: 10.1080/21645515.2020.1824968</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Самойлович Е. О. Надзор за вакциноуправляемыми инфекциями в Республике Беларусь: соответствие международным стандартам. Здравоохранение. 2014(6):7–11. Доступно на: https://www.zdrav.by/infektologiya-i-epidemiologiya/nadzor-za-vaktsinoupravlyaemymi-infektsiyami-v-respublike-belarus-sootvetstvie-mezhdunarodnym-standartam/</mixed-citation><mixed-citation xml:lang="en">Samoilovich E.O. Supervision of vaccine-controlled infections in the Republic of Belarus: compliance with international standards. Healthcare. 2014(6):7–11 (In Russ.). Available аt: https://www.zdrav.by/infektologiya-i-epidemiologiya/nadzor-za-vaktsinoupravlyaemymi-infektsiyami-v-respublike-belarus-sootvetstvie-mezhdunarodnym-standartam/</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">US Commission on Chronic Illness (1957). Chronic Illness in the US. Vol. I. Prevention of Chronic Illness. Cambridge, Mass: Harvard University Press [internet]. Доступно на: http://www.hup.harvard.edu/catalog.php?isbn=9780674497474</mixed-citation><mixed-citation xml:lang="en">US Commission on Chronic Illness (1957). Chronic Illness in the US. Vol. I. Prevention of Chronic Illness. Cambridge, Mass: Harvard University Press [internet]. Available et: http://www.hup.harvard.edu/catalog.php?isbn=9780674497474</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Программы скрининга: краткое руководство. Повышение эффективности, максимальное увеличение пользы и минимизация вреда. Копенгаген: Европейское региональное бюро ВОЗ; 2020:72 с. Лицензия: CC BY-NC-SA 3.0 IGO.</mixed-citation><mixed-citation xml:lang="en">Screening programmes: a short guide. Increase effectiveness, maximize bene fits and minimize harm]. Regional Office for Europe WHO; 2020:59. ISBN 978 92 890 5478 2, Available аt: www.euro.who</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Драпкина О. М., Самородская И. В. Скрининг: терминология, принципы и международный опыт. Профилактическая медицина. 2019;22(1):90–97. https://doi.org/10.17116/profmed20192201190</mixed-citation><mixed-citation xml:lang="en">Drapkina O. M., Samorodskaia I. V. Screening: terminology, principles and international experience. Profilakticheskaya Meditsina. 2019;22(1):90–97 (In Russ.). https://doi.org/10.17116/profmed20192201190</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
